| Trial ID: | L2037 |
| Source ID: | NCT03125694
|
| Associated Drug: |
Sitagliptin 100mg
|
| Title: |
Sitagliptin vs. Pioglitazone as add-on Treatments in Patients With Type 2 Diabetes Uncontrolled on the Full-dose Metformin Plus Sulfonylurea
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Uncontrolled Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Sitagliptin 100mg|DRUG: Pioglitazone 30 mg
|
| Outcome Measures: |
Primary: Change from baseline in mean glycated hemoglobin (A1C) levels by sitagliptin vs. pioglitazone, 52 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Tehran University of Medical Sciences
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
250
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2015-02-01
|
| Completion Date: |
2017-04-01
|
| Results First Posted: |
|
| Last Update Posted: |
2017-04-24
|
| Locations: |
Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT03125694
|
